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INTRODUCTION
The incidence and mortality of renal failure remain high
[1]. Dialysis continues to be a major supportive
intervention in renal failure, but late referral for dialysis
is associated with a higher risk of morbidity and
mortality [2–4]. Recent studies indicate that as many
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current treatment, initial laboratory values and vascular access type were determined.
Results: Ninety patients (52 male, 38 female; mean age, 56.63 ± 17.33 years) were included in the study.
The most common presenting complaints were dyspnea, weakness and edema. Twenty (22.2%) patients had
acute renal failure and the other 70 patients had chronic renal failure. Only seven (7.7%) patients had the
necessary documents for dialysis treatment, and only six patients had available radial arteriovenous fistula.
During follow-up, eight (8.8%) patients died. We found inadequate hemodialysis readiness in our end-stage
renal disease patients.
Conclusion: Improving the quality of pre-dialysis care might improve long-term survival, so appropriate timing
for nephrology referral is important in patients with end-stage renal disease. [Hong Kong J Nephrol 2007;9(2):
82–5]
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as 60% of end-stage renal disease patients begin dialysis
less than 3 months post-referral to a renal unit [3–6];
on the other hand, it is estimated that 20–50% of adult
patients start chronic dialysis therapy without prior
contact with a nephrologist [7]. The percentage of late
referral patients varies widely from center to center.
Late referral has been described as being associated
Hong Kong J Nephrol • October 2007 • Vol 9 • No 2 83
Analysis of dialysis patients
with uremic symptoms, anemia, and derangement in
calcium and phosphate homeostasis, prolonged
hospitalization and increased mortality. For many of
these patients, dialysis treatment must be started under
emergency conditions [3]. Many patients require central
venous catheter insertion with all of its associated
complications [3,8]. These patients experience poor
general health, high incidence of untreated uremic
complications, increased risk of catastrophic dialysis
onset, and increased health care costs once dialysis
begins [4]. Late referral was associated with higher risk
of death at 1 year after initiation of dialysis [9].
Therefore, the late nephrological referral of renal pa-
tients remains a public health problem of consi-
derable importance and represents a particularly un-
fortunate situation considering the recent advances in
managing chronic kidney disease progression and
controlling complications [4,10]. The aim of this study
was to determine the frequency of late referral and
emergency dialysis needed in our patient population.
SUBJECTS AND METHODS
This study was a retrospective analysis of 90 patients
who required immediate hemodialysis treatment after
presenting to the emergency unit of Haseki Training
and Research Hospital, Turkey, between August 2003
and June 2005. All consecutive patients in need of renal
replacement therapy, chronic or acute, were enrolled.
Their demographic data, presenting complaints, co-
morbid conditions, renal disease etiologies, vascu-
lar access type, medications and laboratory values
(creatinine, calcium, phosphorus, sodium, potassium,
albumin, hematocrit) were collected from their hospi-
tal charts after obtaining written informed consent.
Dialysis data were retrieved from dialysis charts. Re-
sults are presented as mean ± standard deviation (SD)
or as a percentage.
RESULTS
A total of 90 patients (mean age, 56.63 ± 17.33 years;
age range, 21–80 years) were included in the study.
There were 52 men (mean age, 53.12 ± 17.97 years)
and 38 women (mean age, 57.71 ± 16.80 years). The
most common presenting complaints were dyspnea,
weakness and edema. Six (6.6%) patients were
unconscious, six (6.6%) patients had dysuria, and 22
(24.4%) had severe hypertension. Twenty (22.2%)
patients had acute renal failure, and the other 70 patients
had chronic renal failure (7.14% postrenal, 17.1%
glomerulonephritis, 4.2% nephrolithiasis, 4.28%
pyelonephritis, 2.8% polycystic kidney disease, 27.1%
diabetic nephropathy, 28.8% unknown etiology).
Seventy (77.7%) patients were not aware of their
diagnosis, and 17 (18.8%) patients had been diagnosed
in the last 3 months. Only seven (7.7%) patients had
the necessary medical care and insurance documents
for dialysis treatment.
Seventeen (18.8%) jugular, 13 (14.4%) femoral,
and 54 (60%) subclavian catheters were used for
vascular access. Only six (6.6%) patients had available
radial arteriovenous fistula. Three (3.3%) patients
were taking angiotensin-converting enzyme inhibitors,
10 (11.1%) were taking erythropoietin, 19 (21.1%)
iron, 16 (17.7%) vitamin D, and 27 (30%) were taking
calcium carbonate. The presenting laboratory findings
are shown in the Table.
During follow-up, eight (8.8%) patients died. Five
(5.5%) patients did not require further dialysis; the
remaining patients continued with the chronic
hemodialysis program.
DISCUSSION
The number of patients with end-stage renal disease
requiring renal replacement therapy is constantly
increasing [3]. Many chronic renal failure patients
present to the emergency unit with a need for dialysis
[3–5]. Ideal management of advanced chronic kidney
disease includes timely dialysis preparation, and an
informed choice of the most appropriate dialysis
method [4]. The prognosis and outcome in patients with
end-stage renal disease is significantly related to
predialysis care and early or late nephrological referral
[11]. Late referral to nephrologists of patients with
chronic kidney disease is a major public health problem
[12]. As in the literature, we also discovered inadequate
hemodialysis preparation in our end-stage renal disease
patients. Late referral is associated with a greater risk
of emergency, unplanned initiation of dialysis, higher
hospital costs, longer duration of initial hospitalization,
and worse long-term survival on renal replacement
therapy [5,12]. Late referral was associated with a
higher risk of death at 1 year after initiation of dialysis
[9]. Of our patients, 68 were late referrals and eight of
them died. In our national registry (2004), it was
Table. Presenting laboratory findings of the chronic renal failure
patients
Mean Range
Creatinine (mg/dL) 7.85 ± 4.82 2.8–18.7
Calcium (mg/dL) 7.52 ± 1.51 3.6–11.0
Phosphate (mg/dL) 5.19 ± 1.91 3.0–12.6
Sodium (mmol/L) 134.52 ± 5.93 114.0–146.0
Potassium (mmol/L) 4.81 ± 1.07 3.0–7.6
Albumin (g/dL) 3.22 ± 0.72 1.2–4.7
Hematocrit (%) 28.00 ± 7.83 17.4–53.6
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reported that 31% of hemodialysis patients die within
the first 3 months of dialysis [13]. The main problem
with late referral is not that the time is insufficient to
prepare the patient for renal replacement therapy, but
more that late referral patients do not have the
opportunity for timely treatment of the factors leading
to vascular comorbidity such as hypertension, anemia,
hypervolemia, hyperlipidemia or hyperphosphatemia
[3]. We determined anemic values in our patients (mean
hematocrit was 28 ± 7.83%). Clinical studies have
shown that anemia is associated with reduced survival
in patients with renal disease [14]. There is good
evidence to suggest that achieving adequate hematocrit
levels reduces morbidity and mortality in patients with
end-stage renal disease [15]. Therefore, anemia
management should begin as early as possible [16].
Likewise, hypoalbuminemia is a powerful predictor of
mortality in patients with chronic renal failure, and the
major cause of it in this population is cardiovascular
events [17]. Our patients had hypoalbuminemic values
(albumin 3.22 ± 0.72 g/dL). Hypoalbuminemia is
common in patients with end-stage renal disease [18].
Most patients with progressive chronic renal disease
develop hyperphosphatemia. An elevated phosphate
level is an important risk factor for the development of
calcification and cardiovascular mortality in chronic
renal disease patients [19]. But we did not decrease
high phosphate levels in our patients. We found that
22 patients had severe hypertension and 19 patients
had diabetes. Diabetic patients are prone to vascular ac-
cess problems. We also found that only six patients
had available radial arteriovenous fistula. Some
investigators have shown that placement of a catheter
or graft, instead of the timely construction of an
arteriovenous fistula, and unplanned dialysis increase
morbidity and mortality in chronic renal failure patients
[3,8]. Furthermore, a delay in providing an adequate
arteriovenous fistula entails significant increases in
treatment-related costs [8]. Late nephrologist referral
is an independent risk factor for early death on dialysis
[20]. These findings suggest that several factors increase
the risk that patients with chronic kidney disease will
have their first nephrologist consultation excessively
late in the course of their disease. To reduce the high
mortality rate on dialysis, patients should receive
professional nephrological care as early as possible in
the course of renal disease, not only to slow renal failure
progression, but equally importantly to prevent or treat
comorbidities, especially vascular disease, early and
aggressively [4].
The detrimental effects of late referral are increased
emergency inpatient dialysis and health care resource
usage. Late referral and the presence of severe co-
morbidities seem to be the most powerful predictors
of a reduced chance to choose the therapy best suited
to the patient's individual lifestyle. Once the patient has
been referred to specialist care, the best clinical practice
is more effective if delivered within the framework of
structured multidisciplinary educational programs. A
National Institute of Health consensus publication
recommends early referral to a multidisciplinary renal
care team, and the recent Canadian Society of
Nephrology guidelines recommend that at least 12
months are needed prior to initiation of dialysis for
adequate medical and psychologic preparation for renal
replacement therapy [21].
Insufficient time for early intervention is reflected
not so much by the period from referral to renal
replacement therapy, but by renal function at the
patient's first visit to a nephrologist. Improving the
quality of predialysis care might improve long-term
survival, so appropriate timing of nephrology referral
is important in patients with end-stage renal disease.
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